Literature DB >> 18299363

Self-inflating bag or Mapleson C breathing system for emergency pre-oxygenation?

R A Stafford1, J R Benger, J Nolan.   

Abstract

BACKGROUND: A crossover study was performed in healthy volunteers to compare the efficacy of a self-inflating bag with the Mapleson C breathing system for pre-oxygenation.
METHOD: 20 subjects breathed 100% oxygen for 3 min using each device, with a 30 min washout period. The end tidal oxygen concentration and subjective ease of breathing were compared.
RESULTS: There was a statistically significant difference in performance between the two devices, with the Mapleson C providing higher end expiratory oxygen concentrations at 3 min. The mean (SD) end expiratory oxygen concentration was 74.2 (3.8)% for the self-inflating bag (95% CI 72.4% to 75.9%) and 86.2 (3.7)% for the Mapleson C system (95% CI 84.5 to 88.0); p<0.0001. The 95% CI of the difference between the mean values for end expiratory oxygen concentration at 3 min was 10.0% to 14.2%. There was also a statistically significant difference in the subjective ease of breathing, favouring the Mapleson C system.
CONCLUSION: The Mapleson C breathing system is more effective and subjectively easier to breathe through than a self-inflating bag when used for pre-oxygenation. However, these benefits must be weighed against the increased level of skill required and possible complications when using a Mapleson C breathing system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299363     DOI: 10.1136/emj.2007.050708

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  2 in total

1.  Evaluation of the self-inflating bag-valve-mask and non-rebreather mask as preoxygenation devices in volunteers.

Authors:  Amelia Robinson; Ari Ercole
Journal:  BMJ Open       Date:  2012-10-26       Impact factor: 2.692

Review 2.  Development of a standard operating procedure and checklist for rapid sequence induction in the critically ill.

Authors:  Peter Brendon Sherren; Stephen Tricklebank; Guy Glover
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-09-11       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.